Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Inventory (2016 - 2025)

Iradimed (IRMD) has disclosed Inventory for 13 consecutive years, with $11.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory rose 4.3% to $11.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.7 million, a 4.3% increase, with the full-year FY2024 number at $10.9 million, down 17.61% from a year prior.
  • Inventory was $11.7 million for Q3 2025 at Iradimed, roughly flat from $11.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $13.2 million in Q4 2023 to a low of $4.3 million in Q4 2021.
  • A 5-year average of $8.4 million and a median of $8.4 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: soared 146.63% in 2023, then dropped 17.61% in 2024.
  • Iradimed's Inventory stood at $4.3 million in 2021, then rose by 24.87% to $5.4 million in 2022, then skyrocketed by 146.63% to $13.2 million in 2023, then decreased by 17.61% to $10.9 million in 2024, then rose by 7.56% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Inventory are $11.7 million (Q3 2025), $11.7 million (Q2 2025), and $11.0 million (Q1 2025).